About Index Trending news
Analyze
Top 50 Pricing
Aerie Pharmaceuticals

Aerie Pharmaceuticals

Work at Aerie Pharmaceuticals? Add yourself to this profile

Aerie Pharmaceuticals

Aerie Pharmaceuticals is focused on developing products for the pharmaceuticaltreatment of glaucoma.

Elsewhere

Alexa global traffic share

Latest funding Show all
Post-IPO equity
$125,000,000
Post-IPO equity
$125,000,000
Employees

Team size

10+
Locations
HQ
Headquarters
$125,000,000 Post-IPO equity
businesswire

Aerie Pharmaceuticals Raises $125 Million in Public Offerings | Business Wire

The Motley Fool

Why Safety Data Is Sending Aerie Pharmaceuticals Soaring Today

Stock markets